Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 148

    1.

    Presence of the metabolic syndrome does not impair coronary collateral vessel formation in patients with documented coronary artery disease.

    Olijhoek JK, Koerselman J, de Jaegere PP, Verhaar MC, Grobbee DE, van der Graaf Y, Visseren FL; SMART Study Group.

    Diabetes Care. 2005 Mar;28(3):683-9.PMID: 15735208 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Impaired coronary collateral vessel development in patients with metabolic syndrome.

    Turhan H, Yasar AS, Erbay AR, Yetkin E, Sasmaz H, Sabah I.

    Coron Artery Dis. 2005 Aug;16(5):281-5.PMID: 16000885 [PubMed - indexed for MEDLINE]Related articles

    3.

    Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study.

    Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB Sr, Wilson PW.

    Diabetes. 2005 Nov;54(11):3252-7.PMID: 16249452 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Comparison between HOMA-IR and ISI-gly in detecting subjects with the metabolic syndrome.

    Carnevale Schianca GP, Sainaghi PP, Castello L, Rapetti R, Limoncini AM, Bartoli E.

    Diabetes Metab Res Rev. 2006 Mar-Apr;22(2):111-7.PMID: 16052601 [PubMed - indexed for MEDLINE]Related articles

    5.

    Association of low adiponectin levels with the metabolic syndrome--the Chennai Urban Rural Epidemiology Study (CURES-4).

    Mohan V, Deepa R, Pradeepa R, Vimaleswaran KS, Mohan A, Velmurugan K, Radha V.

    Metabolism. 2005 Apr;54(4):476-81.PMID: 15798954 [PubMed - indexed for MEDLINE]Related articles

    6.

    Incidence and clinical characteristics of the metabolic syndrome in patients with coronary artery disease.

    Solymoss BC, Bourassa MG, Lespérance J, Levesque S, Marcil M, Varga S, Campeau L.

    Coron Artery Dis. 2003 May;14(3):207-12.PMID: 12702923 [PubMed - indexed for MEDLINE]Related articles

    7.

    Metabolic syndrome and collateral vessel formation in patients with documented occluded coronary arteries: association with hyperglycaemia, insulin-resistance, adiponectin and plasminogen activator inhibitor-1.

    Mouquet F, Cuilleret F, Susen S, Sautière K, Marboeuf P, Ennezat PV, McFadden E, Pigny P, Richard F, Hennache B, Vantyghem MC, Bertrand M, Dallongeville J, Jude B, Van Belle E.

    Eur Heart J. 2009 Apr;30(7):840-9. Epub 2009 Jan 22.PMID: 19164335 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study.

    Patel DA, Srinivasan SR, Xu JH, Chen W, Berenson GS.

    Metabolism. 2006 Nov;55(11):1551-7.PMID: 17046560 [PubMed - indexed for MEDLINE]Related articles

    10.

    Association of A1C with cardiovascular disease and metabolic syndrome in Asian Indians with normal glucose tolerance.

    Dilley J, Ganesan A, Deepa R, Deepa M, Sharada G, Williams OD, Mohan V.

    Diabetes Care. 2007 Jun;30(6):1527-32. Epub 2007 Mar 10.PMID: 17351274 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Relation of coronary collateral vessel development in patients with a totally occluded right coronary artery to the metabolic syndrome.

    Yilmaz MB, Caldir V, Guray Y, Guray U, Altay H, Demirkan B, Cay S, Kisacik HL, Korkmaz S.

    Am J Cardiol. 2006 Mar 1;97(5):636-9. Epub 2006 Jan 6.PMID: 16490428 [PubMed - indexed for MEDLINE]Related articles

    12.

    Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study.

    Becker B, Kronenberg F, Kielstein JT, Haller H, Morath C, Ritz E, Fliser D; MMKD Study Group.

    J Am Soc Nephrol. 2005 Apr;16(4):1091-8. Epub 2005 Mar 2.PMID: 15743998 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Can the metabolic syndrome identify children with insulin resistance?

    Hirschler V, Calcagno ML, Aranda C, Maccallini G, Jadzinsky M.

    Pediatr Diabetes. 2007 Oct;8(5):272-7.PMID: 17850470 [PubMed - indexed for MEDLINE]Related articles

    14.

    Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects.

    Roos A, Bakker SJ, Links TP, Gans RO, Wolffenbuttel BH.

    J Clin Endocrinol Metab. 2007 Feb;92(2):491-6. Epub 2006 Nov 7.PMID: 17090642 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Plasma adiponectin levels in high risk African-Americans with normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes.

    Osei K, Gaillard T, Schuster D.

    Obes Res. 2005 Jan;13(1):179-85.PMID: 15761178 [PubMed - indexed for MEDLINE]Related articles

    16.

    Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome.

    Yilmaz M, Bukan N, Ersoy R, Karakoç A, Yetkin I, Ayvaz G, Cakir N, Arslan M.

    Hum Reprod. 2005 Sep;20(9):2414-20. Epub 2005 May 12.PMID: 15890734 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome.

    Valle M, Martos R, Gascón F, Cañete R, Zafra MA, Morales R.

    Diabetes Metab. 2005 Feb;31(1):55-62.PMID: 15803114 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Beneficial effects of fenofibrate to improve endothelial dysfunction and raise adiponectin levels in patients with primary hypertriglyceridemia.

    Koh KK, Han SH, Quon MJ, Yeal Ahn J, Shin EK.

    Diabetes Care. 2005 Jun;28(6):1419-24.PMID: 15920062 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation.

    Onat A, Hergenç G, Türkmen S, Yazici M, Sari I, Can G.

    Metabolism. 2006 Apr;55(4):445-52.PMID: 16546474 [PubMed - indexed for MEDLINE]Related articles

    20.

    Incidence and angiographic predictors of collateral function in patients with stable coronary artery disease scheduled for percutaneous coronary intervention.

    de Vries J, Anthonio RL, van den Heuvel AF, Tan ES, Jessurun GA, de Smet BJ, DeJongste MJ, Zijlstra F.

    Catheter Cardiovasc Interv. 2007 Aug 1;70(2):197-202.PMID: 17503495 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data